EUVIMEDEUVIMED entdecken
Open Access

Telemedicine Visit Use and Glycemic Control in Patients With Diabetes

Emilia G Thurber iD, Zhou Lan, Alexander Turchin iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Emilia G Thurber und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Telemedicine, Glycemic Control, COVID-19, Diabetes Mellitus, Type 2. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Endocrinology telemedicine visits increased during the COVID-19 pandemic with unclear impacts on patient outcomes.

Objective

To determine the relationship between different rates and types of telemedicine use and glycemic control in patients with diabetes.

Methods

This was a retrospective cohort study conducted in endocrinology clinics at an integrated health system. Patients were adults with a baseline glycated hemoglobin (HbA1c) measurement in 2020, at least 2 diabetes visits in 2021, and an outcome HbA1c assessment in 2022. The proportion of total visits in 2021 conducted by video or phone was analyzed and the primary outcome was the change in HbA1c between baseline and the 2022 assessment.

Results

The study population (n = 8867) was 51.39% female, with a mean age of 63.90 years and baseline HbA1c of 7.72%. Patients had a mean of 35.09% telemedicine visits in 2021 (25.18% video, 9.91% phone). Between 2020 and 2022, HbA1c decreased by a mean of 0.17%. Multivariable regression analysis adjusted for demographic and clinical covariates demonstrated that higher rates of phone (P = .009) but not video visits were associated with a smaller decrease in HbA1c. When stratified by baseline HbA1c, higher rates of phone visits were associated with a smaller decrease in HbA1c in patients with a baseline HbA1c ≥ 8.0% (P = .001) but not in those with a baseline HbA1c < 8.0%.

Conclusion

Higher rates of phone but not video visits were associated with worse glycemic control in patients with higher baseline HbA1c. Additional research is needed to determine possible causes and strategies for bridging the digital divide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelemedicineGlycemic ControlCOVID-19Diabetes Mellitus, Type 2Diabetes MellitusHumansFemaleMiddle AgedRetrospective StudiesMaleGlycated HemoglobinAgedBlood GlucoseSARS-CoV-2Adult

Stichwörter der Autor:innen

diabeteshealth care deliveryhealth services researchtelemedicine

Substanzen

Glycated Hemoglobinhemoglobin A1c protein, humanBlood Glucose

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Harvard Medical School, Boston, MA 02115, USA.

ORCID-Profile: Emilia G Thurber, Alexander Turchin

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Thurber, E. G., Lan, Z., & Turchin, A. (2025). Telemedicine Visit Use and Glycemic Control in Patients With Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf177

Vancouver

Thurber EG, Lan Z, Turchin A. Telemedicine Visit Use and Glycemic Control in Patients With Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf177

BibTeX
@article{Thurber2025,
  author = {Thurber, Emilia G and Lan, Zhou and Turchin, Alexander},
  title = {Telemedicine Visit Use and Glycemic Control in Patients With Diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf177}
}
Kostenlos starten →